THE VOGEL GROUP

Lobbying for FORTRESS BIOTECH INC. · Biopharma venture studio that builds, funds, and manages a portfolio of drug-dev companies

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$20,000.00

What the client paid this registrant for the period.

Client based in

Florida

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

Lobbying activity 1

Health Issues

Give kids a chance act H.R.1262; issues related to rare pediatric disease and priority review vouchers

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.